View Post

Oncoceutics Announces FDA Acceptance of Investigational New Drug Application for Phase I Trial of ONC206

In Clinical Trials by Barbara Jacoby

Oncoceutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for ONC206, allowing the first-in-human trial of the compound. ONC206 is the first of the family of drug candidates, which we call “imipridones”, that possess the same core chemical structure as ONC201. The first clinical trial for ONC206 in adults …

View Post

Carevive Awarded National Cancer Institute SBIR Fast-Track to Advance Symptom Management Clinical Decision Support Technology

In In The News by Barbara Jacoby

Source: Carevive From: prnewswire.com NCI awards Carevive with the only Fast-Track Phase I/II contract supporting the development of an innovative symptom management and electronic patient-reported outcome solution Carevive, a health technology company that builds cancer care management and patient engagement solutions to improve patient quality of life and clinical outcomes, announced today that it has been awarded a Phase I …

View Post

New Study Shows a Decline in the Incidence of Recurrent Metastatic Breast Cancer Over Time but no Improvement in Survival

In In The News by Barbara Jacoby

From: prnewswire.com A retrospective analysis –  reported in the journal Breast Cancer Research and Treatment, by Judith Malmgren, PhD, and co-authors – studied 8292 women with stage I-III invasive breast cancer, 964 of whom (11.6%) were later diagnosed with recurrent metastatic breast cancer (rMBC). The authors found a significant decline in rMBC over time, but no increase in survival. Survival …

View Post

Translating Patient Feedback Into Better Cancer Treatments

In Clinical Trials by Barbara Jacoby

From: Cedars-Sinai A major new study now underway aims to better incorporate patient feedback into clinical trials that help determine which new cancer treatments will be approved for use. The project, supported by a five-year, $3.4 million grant from the National Cancer Institute, involves statisticians, clinicians and patient advocates. The team is analyzing data from previous and ongoing clinical trials …

View Post

Blacks, Elderly Missing From U.S. Cancer Clinical Trials

In In The News by Barbara Jacoby

From: drugs.com Four out of five participants in cancer clinical trials are white, a discrepancy that calls into question whether other races and ethnicities are receiving good cancer treatment, researchers say. Women and the elderly also are underrepresented in clinical trials, according to the new findings. Prior studies have shown that the effectiveness of cancer treatment can vary based on …

View Post

How to Find a Clinical Trial: Questions and Tips for Cancer Patients

In In The News by Barbara Jacoby

By: Stav Ziv From: newsweek.com Clinical trials aren’t for every cancer patient. But for some, experimental new treatments can provide hope for a better outcome than standard methods provide. Newsweek spoke with Dr. Sheila Prindiville—a medical oncologist and director of the National Cancer Institute’s (NCI) Coordinating Center for Clinical Trials—about some of the basics, like when cancer patients might want …

View Post

Women With Breast Cancer Miss Out On Recommended Genetic Testing

In In The News by Barbara Jacoby

By: Jessica Boddy From: npr.org Women with breast cancer who are at high risk for having a BRCA mutation that raises cancer risk often don’t get genetic testing, or even a chance to speak with a genetic counselor who’d help them weigh the necessity of such a test, a study finds. Mutations in the BRCA1 and BRCA2 genes increase the …

View Post

National Cancer Institute uses API to connect patients with clinical trials

In In The News by Barbara Jacoby

By: Meredith Somers From: federalnewsradio.com Do you have lung cancer? Is it a carcinoma, sarcoma, melanoma, lymphoma or leukemia? Is your lung cancer small or non-small cell? What stage is your cancer, and is it recurrent? Perhaps you should try treating your lung cancer with Cyclodextrin-based polymer-camptothecin CRLX101 and Olaparib. Or ATR Kinase Inhibitor VX-970 and Topotecan Hydrochloride. A cancer diagnosis itself can …

View Post

Cancer-Fighting Drugs Under Testing in North Texas

In In The News by Barbara Jacoby

By: Bianca Castro From: nbcdfw.com Clinical trials that could change the future of cancer medicine are happening here in North Texas, offering patients hope at a cure and giving doctors new tools in the cancer fight. Several of those trials are happening at Texas Oncology of Fort Worth, where Sulphur Springs resident Emily Herschler was treated for ovarian cancer. “My …

View Post

NASA data scientists are helping fight cancer

In In The News by Barbara Jacoby

By: Brooks Hays From: upi.com Researchers with the National Cancer Institute continue to make cancer-fighting discoveries using data analysis techniques developed by data scientists at NASA’s Jet Propulsion Laboratory. NASA scientists are constantly trying to figure out ways to manage and mine the data being pulled in by the many instruments and sensors attached to their exhaustive catalogue of probes, …